Table 3.
Donor protein | Acceptor protein | Pearson’s correlation coefficient ±SD | Donor lifetime TD (ns)±SD | Donor lifetime in the presence of potential acceptor TDA (ns)±SD | FRET efficiency, EFRET (%) |
---|---|---|---|---|---|
eGFP | mRFP | 0.95±0.02 | 2.43 ns±0.03 | 2.31 ns±0.04 | 5% |
AtPS1–GFP | AtAPH-1–RFP | 0.83±0.04 | 2.39 ns±0.02 | 1.94 ns±0.03 | 19% |
AtAtPS2–GFP | AtAPH-1–RFP | 0.91±0.03 | 2.39 ns±0.05 | 1.91 ns±0.09 | 20% |
AtPEN-2–GFP | AtAPH-1–RFP | 0.72±0.03 | 2.34 ns±0.02 | 2.33 ns±0.11 | 0.5% |
AtNCT–GFP | AtAPH-1–RFP | 0.84±0.03 | 2.36 ns±0.12 | 2.04 ns±0.04 | 14% |
AtPS1–GFP | AtNCT–RFP | 0.85±0.02 | 2.39 ns±0.02 | 1.93 ns±0.02 | 19% |
AtPEN-2–GFP | AtNCT–RFP | 0.81±0.05 | 2.34 ns±0.02 | 2.00 ns±0.07 | 11% |
AtPS1–GFP | AtPEN-2–RFP | 0.91±0.05 | 2.39 ns±0.02 | 1.81 ns±0.12 | 24% |
AtPS2–GFP | AtPEN-2–RFP | 0.78±0.05 | 2.39 ns±0.05 | 1.63 ns±0.22 | 32% |
AtPEN-2N74L–GFP | AtPS2–RFP | 0.89±0.04 | 2.36 ns±0.03 | 2.34 ns±0.03 | 1% |